Selective Anticancer Activity of Acacetin Against Chronic Lymphocytic Leukemia Using Both In Vivo and In Vitro Methods: Key Role of Oxidative Stress and Cancerous Mitochondria

Nutrition and Cancer

Volumn 68, Issue 8, 2016, Pages 1404-1416

  Salimi, Ahmad ^a,b   Roudkenar, Mehryar Habibi ^c   Sadeghi, Leila ^d   Mohseni, Alireza ^e   Seydi, Enayatollah ^a   Pirahmadi, Nahal ^a   Pourahmad, Jalal ^a,f  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ARDABIL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f Pharmaceutical Sciences Research Center   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ACACETIN; ANTILEUKEMIC AGENT; CASPASE 3; CYTOCHROME C; REACTIVE OXYGEN METABOLITE; SUCCINATE DEHYDROGENASE; ANTINEOPLASTIC AGENT; FLAVONE DERIVATIVE; MATRIX METALLOPROTEINASE;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CANCER PATIENT; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL TOXICITY; MITOCHONDRION SWELLING; MOUSE; NONHUMAN; OXIDATIVE STRESS; ANIMAL; DRUG EFFECTS; DRUG SCREENING; METABOLISM; MIDDLE AGED; MITOCHONDRION; PATHOLOGY; SCID MOUSE;

AGED; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; B-LYMPHOCYTES; CYTOCHROMES C; FLAVONES; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MATRIX METALLOPROTEINASES; MICE, SCID; MIDDLE AGED; MITOCHONDRIA; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84992361841     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2016.1235717     Document Type: Article

References (26)

1. L.Z.Rassenti, S.Jain, M.J.Keating, W.G.Wierda, M.R.Grever,:Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia. Blood 112(5), 1923–1930, 2008.
2. E.Landfeldt, J.Eriksson, S.Ireland, P.Musingarimi, C.Jackson,:Patient, physician, and general population preferences for treatment characteristics in relapsed or refractory chronic lymphocytic leukemia:a conjoint analysis. Leuk Res 40, 17–23, 2016.
3. T.Rich, R.L.Allen, and A.H.Wyllie:Defying death after DNA damage. Nature 407(6805), 777–783, 2000.
4. S.Fulda:Targeting Extrinsic Apoptosis in Cancer:Challenges and Opportunities. Semin Cell Dev Biol 39, 20–25, 2015.
5. F.L.Kiechle and X.Zhang:Apoptosis:biochemical aspects and clinical implications. Clin Chim Acta 326(1), 27–45, 2002.
6. N.J.Waterhouse, J.C.Goldstein, R.M.Kluck, D.D.Newmeyer, and D.R.Green:The (Holey) study of mitochondria in apoptosis. Methods Cell Biol 66(2), 365–391, 2001.
7. W.Lu, M.A.Ogasawara, and P.Huang:Models of reactive oxygen species in cancer. Drug Discov Today Dis Models 4(2), 67–73, 2007.
8. J.Lopez and S.Tait:Mitochondrial apoptosis:killing cancer using the enemy within. Br J Cancer 112(6), 957–962, 2015.
9. T.A.Bhat, D.Nambiar, D.Tailor, A.Pal, R.Agarwal,:Acacetin inhibits in vitro and in vivo angiogenesis and downregulates stat signaling and VEGF expression. Cancer Prev Res 6(10), 1128–1139, 2013.
10. H.R.Kim, C.G.Park, and J.Y.Jung:Acacetin (5, 7-dihydroxy-4'-methoxyflavone) exhibits in vitro and in vivo anticancer activity through the suppression of NF-κB/Akt signaling in prostate cancer cells. Int J Mol Med 33(2), 317–324, 2014.
11. L.-N.Qiu, Y.-L.Zhou, Z.-N.Wang, Q.Huang, and W.-X.Hu:ZGDHu-1 promotes apoptosis of chronic lymphocytic leukemia cells. Int J Oncol 41(2), 533–540, 2012.
12. A.Salimi, M.H.Roudkenar, L.Sadeghi, A.Mohseni, E.Seydi,:Ellagic acid, a polyphenolic compound, selectively induces ROS-mediated apoptosis in cancerous B-lymphocytes of CLL patients by directly targeting mitochondria. Redox Biol 6, 461–471, 2015.
13. F.Wang, J.-L.Yang, Y.K-kYu, M.Xu, Y.-Z.Xu,:Activation of the NF-κB pathway as a mechanism of alcohol enhanced progression and metastasis of human hepatocellular carcinoma. Mol Cancer 14(1), 10, 2015.
14. J.-J.Li, Q.Tang, Y.Li, B.-R.Hu, Z.-Y.Ming,:Role of oxidative stress in the apoptosis of hepatocellular carcinoma induced by combination of arsenic trioxide and ascorbic acid. Acta Pharmacol Sin 27(8), 1078–1084, 2006.
15. K.W.Wahle, I.Brown, D.Rotondo, and S.D.Heys:Plant phenolics in the prevention and treatment of cancer. Adv Exp Med Biol 698, 36–51, 2010.
16. D.Hanahan and R.A.Weinberg:The hallmarks of cancer. Cell 100(1), 57–70, 2000.
17. G.Packham and F.K.Stevenson:Bodyguards and assassins:Bcl‐2 family proteins and apoptosis control in chronic lymphocytic leukaemia. Immunology 114(4), 441–449, 2005.
18. M.Hassan, H.Watari, A.AbuAlmaaty, Y.Ohba, N.Sakuragi:Apoptosis and Molecular Targeting Therapy in Cancer BioMed Res Int 1–23, 2012.
19. H.Shim, J.Park, H.Paik, S.Nah, D.Kim,:Acacetin-induced apoptosis of human breast cancer MCF-7 cells involves caspase cascade, mitochondria-mediated death signaling and SAPK/JNK1/2-c-Jun activation. Mol Cell Biol 24(1), 95, 2007.
20. M.-H.Pan, C.-S.Lai, P.-C.Hsu, and Y.-J.Wang:Acacetin induces apoptosis in human gastric carcinoma cells accompanied by activation of caspase cascades and production of reactive oxygen species. J Agric Food Chem 53(3), 620–630, 2005.
21. J.S.Modica-Napolitano and K.Singh:Mitochondria as targets for detection and treatment of cancer. Expert Rev Mol Med 4(09), 1–19, 2002.
22. D.Trachootham, H.Zhang, W.Zhang, L.Feng, M.Du,:Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism. Blood 112(5), 1912–1922, 2008.
23. G.Chen, F.Wang, D.Trachootham, and P.Huang:Preferential killing of cancer cells with mitochondrial dysfunction by natural compounds. Mitochondrion 10(6), 614–625, 2010.
24. M.Carocho and I.C.Ferreira:A review on antioxidants, prooxidants and related controversy:natural and synthetic compounds, screening and analysis methodologies and future perspectives. Food Chem Toxicol 51, 15–25, 2013
25. Y.Nakamura, K.Torikai, Y.Ohto, A.Murakami, T.Tanaka,:A simple phenolic antioxidant protocatechuic acid enhances tumor promotion and oxidative stress in female ICR mouse skin:dose-and timing-dependent enhancement and involvement of bioactivation by tyrosinase. Carcinogenesis 21, 1899–1907, 2000.
26. G.Galati and P.J.O'Brien:Potential toxicity of flavonoids and other dietary phenolics:significance for their chemopreventive and anticancer properties. Free Radic Biol Med 37(10), 287–303, 2004.